News Center

Do not delete those with high parallax!!

Focus on Yuanshu, News Information

News Information

Industry News

Company News

Yuanshu Pharmaceutical Granted Patent for Synthesis of GnRH Receptor Antagonist Intermediate

2023-01-10

Yuanshu Pharmaceutical Granted Patent for New Camphorquinone Synthesis Method

2023-01-10

Yuanshu Pharmaceutical Attends Qixia District Quality Management Certification Enhancement Project Kick-off Meeting

2022-07-07

Leaders of Qixia District Quality Department and Jiangsu Tiangui Certified Experts went to our company to conduct physical examination and guidance on quality system operation.

2022-07-04

Yuanshu Pharmaceutical's Geriatric Disease Aromatic Hydrocarbon Intermediate R&D Project Approved in 2021 Qixia District Key R&D Program

2022-06-08

Yuanshu Advantage Product Recommendation: N,N'-(2-hydroxy -1,3-propanediyl) bis [N-(2-hydroxyethyl) hexadecanamide]

2022-03-30

Yuanshu Advantage Product Recommendation: Modified Bisphenol A Epoxy Resin

2022-03-18

Yuanshu Advantage Product Recommendation: Coconut Oil Chloride

2022-03-17

< 12345 >
Yuanshu

©2023 Nanjing Yuanshu Pharmaceutical Technology Co., Ltd. Website Construction: China Enterprise Power Nanjing

SEO Tags  |  Website construction: * * * * *

SuICPB 16035393-1

Sugong Network Security32011302321943

Business license
Yuanshu
Yuanshu

309-313,404-408, Block F7, Jiangsu Life Science&Techonlogy Innovation Park，Nanjing,210033,Jiangsu China.

Yuanshu

Operator: 025-84823631
General Manager: 13601462659
Sales: 025-84823350

Picture Name

Mailbox: admin@yspharma.com

Yuanshu
Yuanshu

Concerned about the public.